Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/TRANSGENE-4789/news/BioInvent-and-Transgene-First-patient-treated-in-Part-B-of-Phase-1-trial-assessing-the-novel-oncoly-45039849/?utm_source=whatsapp&utm_medium=social&utm_campaign=share